Page last updated: 2024-10-24

immune response in gut-associated lymphoid tissue

Definition

Target type: biologicalprocess

Immune response taking place in the gut-associated lymphoid tissue (GALT). GALT includes Peyer's patches, appendix, and solitary lymph nodules. [GOC:jal, ISBN:0781735149]

Gut-associated lymphoid tissue (GALT) is a critical component of the mucosal immune system, orchestrating a complex and multifaceted immune response to maintain gut homeostasis and protect against pathogens. The GALT comprises various lymphoid tissues scattered throughout the intestinal tract, including Peyer's patches, isolated lymphoid follicles, and mesenteric lymph nodes.

The GALT employs a sophisticated network of immune cells, including lymphocytes, antigen-presenting cells (APCs), and other immune mediators, to detect and respond to diverse antigens, including commensal bacteria, food antigens, and invading pathogens.

1. **Antigen Recognition and Uptake:** Specialized epithelial cells in the gut, known as M cells, sample luminal contents, including antigens. M cells transport these antigens to underlying lymphoid tissue, where they are presented to APCs like dendritic cells (DCs) and macrophages.
2. **Antigen Presentation and Activation of T cells:** DCs and macrophages process and present antigens to naive T cells in GALT. This interaction activates T cells, triggering their differentiation into effector T cells, including T helper (Th) cells and cytotoxic T lymphocytes (CTLs).
3. **T helper Cell Differentiation:** Activated T cells differentiate into various Th subsets, each with distinct effector functions.
* **Th1 cells:** Produce interferon-gamma (IFN-γ) and TNF-α, promoting cell-mediated immunity against intracellular pathogens.
* **Th2 cells:** Produce IL-4, IL-5, and IL-13, promoting humoral immunity and allergic responses.
* **Th17 cells:** Produce IL-17 and IL-22, mediating inflammatory responses and protecting against extracellular pathogens.
* **Regulatory T cells (Tregs):** Suppress immune responses, maintain tolerance to commensal bacteria, and prevent autoimmunity.
4. **B cell Activation and Antibody Production:** Antigen-activated B cells, stimulated by signals from T cells, differentiate into plasma cells, which produce antibodies specific to the presented antigen. Antibodies can neutralize pathogens, opsonize them for phagocytosis, and activate complement pathways.
5. **Effector Mechanisms:** The diverse effector cells and antibodies generated in GALT engage in various mechanisms to combat pathogens and maintain gut homeostasis:
* **Cell-mediated immunity:** CTLs directly kill infected cells, while Th1 cells activate macrophages and other immune cells.
* **Humoral immunity:** Antibodies neutralize pathogens, opsonize them for phagocytosis, and activate complement pathways.
* **Immune regulation:** Tregs suppress inappropriate immune responses, maintaining tolerance to commensal bacteria and preventing autoimmune reactions.
6. **Memory Response:** The immune response in GALT is characterized by the generation of memory T cells and B cells, which can rapidly mount a robust response upon re-exposure to the same antigen. This memory response is crucial for long-lasting protection against pathogens.

The immune response in GALT is a complex and dynamic process that involves the interplay of multiple cell types and mediators. This intricate network ensures effective protection against pathogens while maintaining tolerance to harmless antigens, contributing to gut homeostasis and overall health.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Integrin beta-7An integrin beta-7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P26010]Homo sapiens (human)
Integrin alpha-4An integrin alpha-4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13612]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
1,3-ditolylguanidine1,3-ditolylguanidine: structure given in first source; a selective ligand for the sigma binding sites in the braintoluenes
cyclopaminepiperidinesglioma-associated oncogene inhibitor
mocetinostatmocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).

mocetinostat: undergoing phase II clinical trials for treatment of cancer
aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
tr 14035N-(2,6-dichlorobenzoyl)-4-(2',6'-bismethoxyphenyl)phenylalanine: TR-14035 is the (L)-isomer; an antagonist of both alpha4beta1 and beta7 integrins; structure in first source
bio 1211BIO 1211: integrin alpha4beta1 inhibitor; structure in first source